What is Lumen?
Founded in 2014, Lumen has established a dominant market position by democratizing access to metabolic data. The company utilizes proprietary hardware and software to measure carbon dioxide concentration in breath, providing users with real-time insights into their metabolic state. This data-driven approach allows individuals to optimize their nutrition, fitness, and recovery protocols based on their unique biological feedback. As the healthtech industry shifts toward hyper-personalization, Lumen remains at the forefront, integrating sophisticated diagnostic capabilities into a user-friendly, consumer-facing ecosystem that addresses the growing demand for precision wellness solutions.
How much funding has Lumen raised?
Lumen has raised a total of $62M across 1 funding round:
Series B
$62M
Series B (2022): $62M with participation from Pitango Venture Capital, RiverPark Ventures, Disruptive VC, Hanwha Group, Almeda Ventures, Resolution Ventures, and Unorthodox Ventures
Key Investors in Lumen
Pitango Venture Capital
Pitango is a venture capital firm that partners with visionary entrepreneurs and groundbreaking companies, supporting them from stealth mode to maturity with a focus on HealthTech and innovation.
Hanwha Group
Hanwha Group is a diversified global conglomerate that harnesses the power of sustainable, quality growth to increase value across sectors including finance, technology, and lifestyle.
Almeda Ventures
Almeda Ventures is a HealthTech-focused public R&D partnership that invests globally in medical devices and digital health, seeking innovative solutions for unmet healthcare needs.
What's next for Lumen?
With this major enterprise-level funding, Lumen is well-positioned to accelerate its international expansion and deepen its research into metabolic health applications. The strategic backing from a diverse group of investors suggests a focus on scaling operations and enhancing the platform's predictive analytics capabilities. Moving forward, the company is expected to prioritize the integration of its metabolic insights into broader digital health platforms, potentially expanding its footprint in the corporate wellness and clinical health markets. By maintaining its commitment to scientific rigor and user-centric design, Lumen is poised to redefine the standards of personalized metabolic optimization on a global scale.
See full Lumen company page
